The effects of GLP-1 infusion in the hepatic portal region on food intake

Dong-Hun Kim, David A. D'Alessio, Stephen C. Woods, Randy J. Seeley

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

A wide range of evidence points to a role for GLP-1 to regulate food intake. Anorectic effects of GLP-1 are most apparent when the peptide is administered directly into the central nervous system (CNS), but suppression of food intake has also been noted in some cases with peripheral administration. It is unclear which GLP-1 receptor (GLP-1r) population mediates the effects of plasma GLP-1, although direct actions to activate CNS neurons have been demonstrated. More recently several groups have demonstrated that GLP-1 can activate peripheral nerves in the hepatic portal vein to regulate glucose metabolism. To test the hypothesis that GLP-1 receptors on nerve terminals in the hepatic portal affect feeding behavior, we compared the effects of direct infusions into hepatic portal and jugular veins in rats. Jugular GLP-1 decreased food intake at doses as low as 10 μg from 0.5-4 h into the dark cycle, whereas portal GLP-1 decreased food intake only at the highest dose tested (100 μg). The blockade of endogenous GLP-1 action before or during eating by infusing dH-Ex, GLP-1 receptor antagonist, into either jugular or portal vein did not cause any change in food intake during either the dark or light cycles. Taken together, these data suggest that while peripheral GLP-1 may be involved in the regulation of food intake, the key GLP-1 receptors are unlikely to be those associated with vagal afferent nerves innervating the hepatic portal vein.

Original languageEnglish
Pages (from-to)110-114
Number of pages5
JournalRegulatory Peptides
Volume155
Issue number1-3
DOIs
Publication statusPublished - 2009 Jun 5
Externally publishedYes

Fingerprint

Glucagon-Like Peptide 1
Eating
Liver
Portal Vein
Hepatic Veins
Jugular Veins
Neurology
Central Nervous System
Appetite Regulation
Appetite Depressants
Photoperiod
Feeding Behavior
Peripheral Nerves
Metabolism
Neurons
Rats
Neck
Plasmas
Glucose
Peptides

Keywords

  • Food intake
  • GLP-1
  • GLP-1 antagonist
  • Hepatic portal GLP-1 receptor
  • Intrajugular or intraportal infusion
  • Rats

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

The effects of GLP-1 infusion in the hepatic portal region on food intake. / Kim, Dong-Hun; D'Alessio, David A.; Woods, Stephen C.; Seeley, Randy J.

In: Regulatory Peptides, Vol. 155, No. 1-3, 05.06.2009, p. 110-114.

Research output: Contribution to journalArticle

Kim, Dong-Hun ; D'Alessio, David A. ; Woods, Stephen C. ; Seeley, Randy J. / The effects of GLP-1 infusion in the hepatic portal region on food intake. In: Regulatory Peptides. 2009 ; Vol. 155, No. 1-3. pp. 110-114.
@article{933a9dfc802144658f81dfea30e1d4a8,
title = "The effects of GLP-1 infusion in the hepatic portal region on food intake",
abstract = "A wide range of evidence points to a role for GLP-1 to regulate food intake. Anorectic effects of GLP-1 are most apparent when the peptide is administered directly into the central nervous system (CNS), but suppression of food intake has also been noted in some cases with peripheral administration. It is unclear which GLP-1 receptor (GLP-1r) population mediates the effects of plasma GLP-1, although direct actions to activate CNS neurons have been demonstrated. More recently several groups have demonstrated that GLP-1 can activate peripheral nerves in the hepatic portal vein to regulate glucose metabolism. To test the hypothesis that GLP-1 receptors on nerve terminals in the hepatic portal affect feeding behavior, we compared the effects of direct infusions into hepatic portal and jugular veins in rats. Jugular GLP-1 decreased food intake at doses as low as 10 μg from 0.5-4 h into the dark cycle, whereas portal GLP-1 decreased food intake only at the highest dose tested (100 μg). The blockade of endogenous GLP-1 action before or during eating by infusing dH-Ex, GLP-1 receptor antagonist, into either jugular or portal vein did not cause any change in food intake during either the dark or light cycles. Taken together, these data suggest that while peripheral GLP-1 may be involved in the regulation of food intake, the key GLP-1 receptors are unlikely to be those associated with vagal afferent nerves innervating the hepatic portal vein.",
keywords = "Food intake, GLP-1, GLP-1 antagonist, Hepatic portal GLP-1 receptor, Intrajugular or intraportal infusion, Rats",
author = "Dong-Hun Kim and D'Alessio, {David A.} and Woods, {Stephen C.} and Seeley, {Randy J.}",
year = "2009",
month = "6",
day = "5",
doi = "10.1016/j.regpep.2009.03.002",
language = "English",
volume = "155",
pages = "110--114",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The effects of GLP-1 infusion in the hepatic portal region on food intake

AU - Kim, Dong-Hun

AU - D'Alessio, David A.

AU - Woods, Stephen C.

AU - Seeley, Randy J.

PY - 2009/6/5

Y1 - 2009/6/5

N2 - A wide range of evidence points to a role for GLP-1 to regulate food intake. Anorectic effects of GLP-1 are most apparent when the peptide is administered directly into the central nervous system (CNS), but suppression of food intake has also been noted in some cases with peripheral administration. It is unclear which GLP-1 receptor (GLP-1r) population mediates the effects of plasma GLP-1, although direct actions to activate CNS neurons have been demonstrated. More recently several groups have demonstrated that GLP-1 can activate peripheral nerves in the hepatic portal vein to regulate glucose metabolism. To test the hypothesis that GLP-1 receptors on nerve terminals in the hepatic portal affect feeding behavior, we compared the effects of direct infusions into hepatic portal and jugular veins in rats. Jugular GLP-1 decreased food intake at doses as low as 10 μg from 0.5-4 h into the dark cycle, whereas portal GLP-1 decreased food intake only at the highest dose tested (100 μg). The blockade of endogenous GLP-1 action before or during eating by infusing dH-Ex, GLP-1 receptor antagonist, into either jugular or portal vein did not cause any change in food intake during either the dark or light cycles. Taken together, these data suggest that while peripheral GLP-1 may be involved in the regulation of food intake, the key GLP-1 receptors are unlikely to be those associated with vagal afferent nerves innervating the hepatic portal vein.

AB - A wide range of evidence points to a role for GLP-1 to regulate food intake. Anorectic effects of GLP-1 are most apparent when the peptide is administered directly into the central nervous system (CNS), but suppression of food intake has also been noted in some cases with peripheral administration. It is unclear which GLP-1 receptor (GLP-1r) population mediates the effects of plasma GLP-1, although direct actions to activate CNS neurons have been demonstrated. More recently several groups have demonstrated that GLP-1 can activate peripheral nerves in the hepatic portal vein to regulate glucose metabolism. To test the hypothesis that GLP-1 receptors on nerve terminals in the hepatic portal affect feeding behavior, we compared the effects of direct infusions into hepatic portal and jugular veins in rats. Jugular GLP-1 decreased food intake at doses as low as 10 μg from 0.5-4 h into the dark cycle, whereas portal GLP-1 decreased food intake only at the highest dose tested (100 μg). The blockade of endogenous GLP-1 action before or during eating by infusing dH-Ex, GLP-1 receptor antagonist, into either jugular or portal vein did not cause any change in food intake during either the dark or light cycles. Taken together, these data suggest that while peripheral GLP-1 may be involved in the regulation of food intake, the key GLP-1 receptors are unlikely to be those associated with vagal afferent nerves innervating the hepatic portal vein.

KW - Food intake

KW - GLP-1

KW - GLP-1 antagonist

KW - Hepatic portal GLP-1 receptor

KW - Intrajugular or intraportal infusion

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=67349148587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349148587&partnerID=8YFLogxK

U2 - 10.1016/j.regpep.2009.03.002

DO - 10.1016/j.regpep.2009.03.002

M3 - Article

VL - 155

SP - 110

EP - 114

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1-3

ER -